Pneumococcal infection
- Humans1
Trial sponsors
Company3 trialsPhase 31,806 people
Company1 trialPhase 1280 people
Company1 trialPhase 163 people
Fakultas Kedokteran Universitas Indonesia
1 trialPhase 456 people
1 trialPhase 456 people
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
1 trialPhase 436 people
National Institute of Allergy and Infectious Diseases
1 trialPhase 160 people
Latest
2 in 12 monthsJournal of Leukocyte Biology
Basal activation of ERK1/2 blunts the antimicrobial activity of neutrophils from old hosts against antibody-opsonized Streptococcus pneumoniae
Study in peopleMechanisms